U.S. gives nod to Eli Lilly's brain plaque test

WASHINGTON, April 7 (Reuters) - U.S. regulators gave the nod
to an imaging test from Eli Lilly and Co. that can for
the first time help doctors detect brain plaque tied to
Alzheimer's disease, the company said.

car insurance salem oregon water damage repair los angeles air conditioner frozen condenser